Blake Porter, MD, is an Assistant Professor at the University of Oklahoma in Oklahoma City. He currently practices all facets of Maternal-Fetal Medicine and is serving as the Co-Medical Director for the Prenatal Diagnostic Center at OU. He earned his MD at the University of Oklahoma College of Medicine in 2010, and completed OB/GYN residency training at the University of Alabama in Birmingham in 2014. His current research includes work in the areas of medical education, ultrasound and fetal growth restriction. He also has special interests in fetal echocardiography, and MFM practice management.
He has won numerous teaching awards including multiple Outstanding Faculty Teacher awards and the APGO Excellence in Teaching Award in 2019.
Dr. Porter’s educational motivation is founded on the humble acknowledgement that everything he has attained has been through the guidance and mentoring of other great educators. He appreciates all his teachers ranging from grade school up to his current colleagues. He tries to live by the mantra that “everyday is a school-day,” and realizes that he will reach far more patients and improve more lives through educating other healthcare providers than by his direct patient care efforts alone.
Dr. Porter’s care philosophy centers on putting the patient first and shared medical decision making. “In my experience, high-risk pregnancies pose one of the greatest challenges in all of medicine. Due to the high complexity and patient-focused care, I found my calling in Maternal-Fetal Medicine to be the most rewarding career that I could imagine. Complicated pregnancies are both emotionally and physically demanding for patients and their expanding families. I strive to educate and empower women and their families to be involved in the process of the healthcare that I deliver. Establishing an excellent patient-physician relationship is important as we align my medical recommendations with a family's goals. My goal is to assist and care for patients during their unique pregnancies in order to optimize both the maternal and fetal outcomes.”
